Market Cap ₹349 Cr.
Stock P/E 18.7
P/B 2.2
Current Price ₹149.8
Book Value ₹ 68.8
Face Value 10
52W High ₹173
Dividend Yield 0%
52W Low ₹ 126.5
Shri Ahimsa Naturals Ltd. is an Indian manufacturer and exporter specializing in natural caffeine and herbal extracts. Established in 1990 and headquartered in Jaipur, Rajasthan, the company processes crude caffeine sourced from decaffeination plants in Vietnam and Mexico. Utilizing proprietary techniques, Shri Ahimsa converts this raw material into high-purity Caffeine Anhydrous Natural and Green Coffee Bean Extracts (GCE), which are widely used in energy drinks, dietary supplements, cosmetics, and pharmaceuticals. In 2022, the company began processing crude caffeine from coffee and tea waste, expanding its product offerings.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
|---|---|---|---|---|
| Net Sales | 58 | 104 | 78 | |
| Other Income | 1 | 2 | 1 | |
| Total Income | 59 | 106 | 79 | |
| Total Expenditure | 41 | 54 | 51 | |
| Operating Profit | 18 | 52 | 27 | |
| Interest | 2 | 1 | 1 | |
| Depreciation | 1 | 1 | 1 | |
| Exceptional Income / Expenses | 0 | 0 | 0 | |
| Profit Before Tax | 16 | 51 | 25 | |
| Provision for Tax | 5 | 13 | 7 | |
| Profit After Tax | 11 | 38 | 19 | |
| Adjustments | 0 | 0 | 0 | |
| Profit After Adjustments | 11 | 38 | 19 | |
| Adjusted Earnings Per Share | 6.1 | 20.9 | 10.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -25% | 0% | 0% | 0% |
| Operating Profit CAGR | -48% | 0% | 0% | 0% |
| PAT CAGR | -50% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | NA% |
| ROE Average | 25% | 50% | 50% | 50% |
| ROCE Average | 31% | 61% | 61% | 61% |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| Shareholder's Funds | 27 | 65 | 84 |
| Minority's Interest | 0 | 0 | 0 |
| Borrowings | 1 | 1 | 0 |
| Other Non-Current Liabilities | 2 | 2 | 2 |
| Total Current Liabilities | 10 | 6 | 17 |
| Total Liabilities | 41 | 74 | 103 |
| Fixed Assets | 21 | 28 | 40 |
| Other Non-Current Assets | 3 | 8 | 10 |
| Total Current Assets | 17 | 38 | 53 |
| Total Assets | 41 | 74 | 103 |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 3 | 10 |
| Cash Flow from Operating Activities | 14 | 20 | 6 |
| Cash Flow from Investing Activities | -6 | -10 | -17 |
| Cash Flow from Financing Activities | -6 | -4 | 10 |
| Net Cash Inflow / Outflow | 3 | 7 | -2 |
| Closing Cash & Cash Equivalent | 3 | 10 | 8 |
| # | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| Earnings Per Share (Rs) | 6.15 | 20.85 | 10.21 |
| CEPS(Rs) | 6.62 | 21.45 | 11.02 |
| DPS(Rs) | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 14.88 | 35.47 | 45.61 |
| Core EBITDA Margin(%) | 29.94 | 48.22 | 34.25 |
| EBIT Margin(%) | 30.15 | 49.32 | 33.27 |
| Pre Tax Margin(%) | 27.56 | 48.78 | 32.47 |
| PAT Margin (%) | 19.41 | 36.69 | 23.95 |
| Cash Profit Margin (%) | 20.9 | 37.75 | 25.85 |
| ROA(%) | 27.76 | 66.62 | 21.1 |
| ROE(%) | 41.33 | 82.83 | 25.17 |
| ROCE(%) | 52.05 | 100.66 | 31.33 |
| Receivable days | 24.65 | 26.56 | 52.71 |
| Inventory Days | 31.6 | 28.05 | 92.44 |
| Payable days | 14.69 | 9.29 | 13.12 |
| PER(x) | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.15 | -0.01 | 0.31 |
| EV/Core EBITDA(x) | 0.49 | -0.02 | 0.88 |
| Net Sales Growth(%) | 0 | 79.27 | -24.94 |
| EBIT Growth(%) | 0 | 193.46 | -49.43 |
| PAT Growth(%) | 0 | 239.15 | -51.06 |
| EPS Growth(%) | 0 | 239.15 | -51.06 |
| Debt/Equity(x) | 0.23 | 0.05 | 0.17 |
| Current Ratio(x) | 1.69 | 6.33 | 3.09 |
| Quick Ratio(x) | 1.18 | 4.51 | 1.43 |
| Interest Cover(x) | 11.64 | 90.84 | 41.85 |
| Total Debt/Mcap(x) | 0 | 0 | 0 |
| # | Mar 2025 |
|---|---|
| Promoter | 68.68 |
| FII | 3.04 |
| DII | 8.59 |
| Public | 19.68 |
| Others | 0 |
| Total | 100 |
| # | Mar 2025 |
|---|---|
| Promoter | 1.6 |
| FII | 0.07 |
| DII | 0.2 |
| Public | 0.46 |
| Others | 0 |
| Total | 2.33 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
